Glutamic acid (GLA) is synthesized from glutamine degradation catalyzed by glutaminase (GLS, comprising GLS1 and GLS2), with GLS2 being a target of the cancer inhibitor gene P53 [[87], [88], [89]]. Here, GLS2 is linked to cancer.